 |
市场调查报告书
商品编码
1342819
全球铜绿假单胞菌感染治疗市场研究报告 - 2023 年至 2030 年行业分析、规模、份额、增长、趋势和预测Global Pseudomonas Aeruginosa Infection Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030 |
||||||
全球铜绿假单胞菌感染治疗市场需求预计将从 2022 年的 45.2 亿美元增至 2030 年的近 88.2 亿美元，2023-2030 年研究期间复合年增长率为 8.72%。
铜绿假单胞菌是一类可在手术后引起个体感染的细菌。这可能会感染血液、肺部或任何其他身体部位。铜绿假单胞菌治疗可能涉及许多有助于减轻个体病情的药物、疗法和程序。抗生素和其他药物通常用于治疗铜绿假单胞菌感染。
市场动态：
由于全球胃肠道感染、尿路感染和呼吸系统感染等医院获得性感染的发病率和患病率不断增加，铜绿假单胞菌感染治疗市场可能会出现显着增长。此外，由于铜绿假单胞菌的流行以及人们对该疾病认识的提高，预计该市场将大幅增长。儘管如此，在临床试验中采用扩张策略和强大的新疗法管道可以为市场参与者提供充足的机会。
该研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球铜绿假单胞菌感染治疗市场的各个细分市场进行了包容性评估。铜绿假单胞菌感染治疗行业的增长和趋势为本研究提供了整体方法。
区域分析：
本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲的铜绿假单胞菌感染治疗市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。
该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。铜绿假单胞菌感染治疗市场的主要参与者包括艾尔建、梯瓦製药工业有限公司、辉瑞公司、卢平製药公司、阿斯利康、默克公司、百时美施贵宝公司、杨森製药公司。包括对竞争格局的整体看法，包括各种战略发展，例如关键併购、未来能力、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。
如果您有任何定制要求，请写信给我们。我们的研究团队可以根据您的需求提供定制报告。
目录
第一章：前言
- 报告说明
- 客观的
- 目标受众
- 独特的销售主张 (USP) 和产品
- 研究范围
- 研究方法论
- 市场研究过程
- 市场研究方法论
第 2 章：执行摘要
- 市场亮点
- 全球市场概况
第 3 章：铜绿假单胞菌感染治疗 - 行业分析
- 简介 - 市场动态
- 市场驱动因素
- 市场限制
- 机会
- 行业动态
- 波特五力分析
- 市场吸引力分析
- 按药物类型分類的市场吸引力分析
- 按药物类型分類的市场吸引力分析
- 按给药途径进行的市场吸引力分析
- 按分销渠道分類的市场吸引力分析
- 市场吸引力分析：按地区
第 4 章：价值链分析
- 价值链分析
- 原材料分析
- 原材料清单
- 原料厂商清单
- 主要原材料价格走势
- 潜在买家名单
- 营销渠道
- 直效行销
- 间接营销
- 营销渠道发展趋势
第 5 章：COVID-19 爆发的影响分析
第 6 章：全球铜绿假单胞菌感染治疗市场分析：按药物类型
- 按药物类型概述
- 历史和预测数据
- 按药物类型分析
- 单一疗法
- 联合疗法
第 7 章：全球铜绿假单胞菌感染治疗市场分析：按药物类型
- 按药物类型概述
- 历史和预测数据
- 按药物类型分析
- 氨基糖苷类
- 头孢菌素
- 碳青霉烯类
- 单菌酰胺
- 其他的
第 8 章：全球铜绿假单胞菌感染治疗市场分析：按给药途径
- 按给药途径概述
- 历史和预测数据
- 按给药途径分析
- 鼻腔
- 口服
- 静脉
第 9 章：全球铜绿假单胞菌感染治疗市场分析：按分销渠道
- 按分销渠道分類的概览
- 历史和预测数据
- 按分销渠道分析
- 医院药房
- 零售药店
- 网上药店
第 10 章：全球铜绿假单胞菌感染治疗市场分析：按地理位置
- 区域展望
- 介绍
- 北美销售分析
- 概述、历史和预测销售分析
- 北美按细分市场销售分析
- 北美按国家/地区销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
- 欧洲销售分析
- 概述、历史和预测销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家/地区销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 意大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
- 亚太地区销售分析
- 概述、历史和预测销售分析
- 亚太地区按细分市场销售分析
- 亚太地区国家/地区销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳大利亚销售分析
- 亚太地区其他地区销售分析
- 拉丁美洲销售分析
- 概述、历史和预测销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家/地区销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
- 中东和非洲销售分析
- 概述、历史和预测销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲国家销售分析
- 沙特阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析
第 11 章：铜绿假单胞菌感染治疗公司的竞争格局
- 铜绿假单胞菌感染治疗市场竞争
- 伙伴关係/协作/协议
- 併购
- 新产品发布
- 其他发展
第 12 章：公司简介
- 顶级公司股票分析
- 市场集中度
- Allergan
- 公司简介
- 公司收入
- 产品
- 最近的发展
- Teva Pharmaceutical Industries Ltd.
- 公司简介
- 公司收入
- 产品
- 最近的发展
- Pfizer Inc.
- 公司简介
- 公司收入
- 产品
- 最近的发展
- Lupin Pharmaceuticals Inc.
- 公司简介
- 公司收入
- 产品
- 最近的发展
- AstraZeneca
- 公司简介
- 公司收入
- 产品
- 最近的发展
- Merck & Co. Inc.
- 公司简介
- 公司收入
- 产品
- 最近的发展
- Bristol-Myers Squibb Co.
- 公司简介
- 公司收入
- 产品
- 最近的发展
- Janssen Pharmaceuticals Inc.
- 公司简介
- 公司收入
- 产品
- 最近的发展
注意 - 在公司概况中，财务详细信息和近期发展视情况而定，或者如果是私营公司，则可能不包括在内
The global demand for Pseudomonas Aeruginosa Infection Treatment Market is presumed to reach the market size of nearly USD 8.82 BN by 2030 from USD 4.52 BN in 2022 with a CAGR of 8.72% under the study period 2023 - 2030.
Pseudomonas aeruginosa is a class of bacteria that can cause infections in individuals after a surgery. This can infect blood, lungs, or any other body part. Pseudomonas aeruginosa treatment may involve a number of drugs, therapies, and procedures that help lessen an individual's condition. Antibiotics and other medications are typically used to treat Pseudomonas aeruginosa infections.
MARKET DYNAMICS:
The pseudomonas aeruginosa infection treatment market is likely to experience remarkable growth owing to the increasing incidence and prevalence of hospital-acquired infections such as gastrointestinal infections, urinary tract infections, and respiratory system infections across the globe. Additionally, the market is estimated to increase significantly owing to the prevalence of pseudomonas aeruginosa and the surge in awareness about the disease. Nonetheless, adopting expansion strategies and a robust pipeline of new therapies in clinical trials could provide ample opportunities for market players.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of pseudomonas aeruginosa infection treatment. The growth and trends of pseudomonas aeruginosa infection treatment industry provide a holistic approach to this study.
MARKET SEGMENTATION:
This section of the pseudomonas aeruginosa infection treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Medication Type
- Monotherapy
- Combination Therapy
By Drug Type
- Aminoglycoside
- Cephalosporin
- Carbapenem
- Monobactam
- Others
By Route Of Administration
- Nasal
- Oral
- Intravenous
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
REGIONAL ANALYSIS:
This section covers the regional outlook, which accentuates current and future demand for the Pseudomonas Aeruginosa Infection Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the pseudomonas aeruginosa infection treatment market include Allergan, Teva Pharmaceutical Industries Ltd., Pfizer Inc., Lupin Pharmaceuticals Inc., AstraZeneca, Merck & Co. Inc., Bristol-Myers Squibb Co., Janssen Pharmaceuticals Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
TABLE OF CONTENTS
1 . PREFACE
- 1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3 . PSEUDOMONAS AERUGINOSA INFECTION TREATMENT - INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porter's Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Medication Type
- 3.7.2 Market Attractiveness Analysis By Drug Type
- 3.7.3 Market Attractiveness Analysis By Route Of Administration
- 3.7.4 Market Attractiveness Analysis By Distribution Channel
- 3.7.5 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
6 . GLOBAL PSEUDOMONAS AERUGINOSA INFECTION TREATMENT MARKET ANALYSIS BY MEDICATION TYPE
- 6.1 Overview by Medication Type
- 6.2 Historical and Forecast Data
- 6.3 Analysis by Medication Type
- 6.4 Monotherapy Historic and Forecast Sales by Regions
- 6.5 Combination Therapy Historic and Forecast Sales by Regions
7 . GLOBAL PSEUDOMONAS AERUGINOSA INFECTION TREATMENT MARKET ANALYSIS BY DRUG TYPE
- 7.1 Overview by Drug Type
- 7.2 Historical and Forecast Data
- 7.3 Analysis by Drug Type
- 7.4 Aminoglycoside Historic and Forecast Sales by Regions
- 7.5 Cephalosporin Historic and Forecast Sales by Regions
- 7.6 Carbapenem Historic and Forecast Sales by Regions
- 7.7 Monobactam Historic and Forecast Sales by Regions
- 7.8 Others Historic and Forecast Sales by Regions
8 . GLOBAL PSEUDOMONAS AERUGINOSA INFECTION TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
- 8.1 Overview by Route Of Administration
- 8.2 Historical and Forecast Data
- 8.3 Analysis by Route Of Administration
- 8.4 Nasal Historic and Forecast Sales by Regions
- 8.5 Oral Historic and Forecast Sales by Regions
- 8.6 Intravenous Historic and Forecast Sales by Regions
9 . GLOBAL PSEUDOMONAS AERUGINOSA INFECTION TREATMENT MARKET ANALYSIS BY DISTRIBUTION CHANNEL
- 9.1 Overview by Distribution Channel
- 9.2 Historical and Forecast Data
- 9.3 Analysis by Distribution Channel
- 9.4 Hospital Pharmacies Historic and Forecast Sales by Regions
- 9.5 Retail Pharmacies Historic and Forecast Sales by Regions
- 9.6 Online Pharmacies Historic and Forecast Sales by Regions
10 . GLOBAL PSEUDOMONAS AERUGINOSA INFECTION TREATMENT MARKET ANALYSIS BY GEOGRAPHY
- 10.1. Regional Outlook
- 10.2. Introduction
- 10.3. North America Sales Analysis
- 10.3.1. Overview, Historic and Forecast Sales Analysis
- 10.3.2. North America By Segment Sales Analysis
- 10.3.3. North America By Country Sales Analysis
- 10.3.4. United State Sales Analysis
- 10.3.5. Canada Sales Analysis
- 10.3.6. Mexico Sales Analysis
- 10.4. Europe Sales Analysis
- 10.4.1. Overview, Historic and Forecast Sales Analysis
- 10.4.2. Europe by Segment Sales Analysis
- 10.4.3. Europe by Country Sales Analysis
- 10.4.4. United Kingdom Sales Analysis
- 10.4.5. France Sales Analysis
- 10.4.6. Germany Sales Analysis
- 10.4.7. Italy Sales Analysis
- 10.4.8. Russia Sales Analysis
- 10.4.9. Rest Of Europe Sales Analysis
- 10.5. Asia Pacific Sales Analysis
- 10.5.1. Overview, Historic and Forecast Sales Analysis
- 10.5.2. Asia Pacific by Segment Sales Analysis
- 10.5.3. Asia Pacific by Country Sales Analysis
- 10.5.4. China Sales Analysis
- 10.5.5. India Sales Analysis
- 10.5.6. Japan Sales Analysis
- 10.5.7. South Korea Sales Analysis
- 10.5.8. Australia Sales Analysis
- 10.5.9. Rest Of Asia Pacific Sales Analysis
- 10.6. Latin America Sales Analysis
- 10.6.1. Overview, Historic and Forecast Sales Analysis
- 10.6.2. Latin America by Segment Sales Analysis
- 10.6.3. Latin America by Country Sales Analysis
- 10.6.4. Brazil Sales Analysis
- 10.6.5. Argentina Sales Analysis
- 10.6.6. Peru Sales Analysis
- 10.6.7. Chile Sales Analysis
- 10.6.8. Rest of Latin America Sales Analysis
- 10.7. Middle East & Africa Sales Analysis
- 10.7.1. Overview, Historic and Forecast Sales Analysis
- 10.7.2. Middle East & Africa by Segment Sales Analysis
- 10.7.3. Middle East & Africa by Country Sales Analysis
- 10.7.4. Saudi Arabia Sales Analysis
- 10.7.5. UAE Sales Analysis
- 10.7.6. Israel Sales Analysis
- 10.7.7. South Africa Sales Analysis
- 10.7.8. Rest Of Middle East And Africa Sales Analysis
11 . COMPETITIVE LANDSCAPE OF THE PSEUDOMONAS AERUGINOSA INFECTION TREATMENT COMPANIES
- 11.1. Pseudomonas Aeruginosa Infection Treatment Market Competition
- 11.2. Partnership/Collaboration/Agreement
- 11.3. Merger And Acquisitions
- 11.4. New Product Launch
- 11.5. Other Developments
12 . COMPANY PROFILES OF PSEUDOMONAS AERUGINOSA INFECTION TREATMENT INDUSTRY
- 12.1. Top Company Share Analysis
- 12.2. Market Concentration Rate
- 12.3. Allergan
- 12.3.1. Company Overview
- 12.3.2. Company Revenue
- 12.3.3. Products
- 12.3.4. Recent Developments
- 12.4. Teva Pharmaceutical Industries Ltd.
- 12.4.1. Company Overview
- 12.4.2. Company Revenue
- 12.4.3. Products
- 12.4.4. Recent Developments
- 12.5. Pfizer Inc.
- 12.5.1. Company Overview
- 12.5.2. Company Revenue
- 12.5.3. Products
- 12.5.4. Recent Developments
- 12.6. Lupin Pharmaceuticals Inc.
- 12.6.1. Company Overview
- 12.6.2. Company Revenue
- 12.6.3. Products
- 12.6.4. Recent Developments
- 12.7. AstraZeneca
- 12.7.1. Company Overview
- 12.7.2. Company Revenue
- 12.7.3. Products
- 12.7.4. Recent Developments
- 12.8. Merck & Co. Inc.
- 12.8.1. Company Overview
- 12.8.2. Company Revenue
- 12.8.3. Products
- 12.8.4. Recent Developments
- 12.9. Bristol-Myers Squibb Co.
- 12.9.1. Company Overview
- 12.9.2. Company Revenue
- 12.9.3. Products
- 12.9.4. Recent Developments
- 12.10. Janssen Pharmaceuticals Inc.
- 12.10.1. Company Overview
- 12.10.2. Company Revenue
- 12.10.3. Products
- 12.10.4. Recent Developments
Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
- Market Snapshot
- Drivers : Impact Analysis
- Restraints : Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- List of Potential Buyers
- Analysis by Medication Type (USD MN)
- Monotherapy Market Sales by Geography (USD MN)
- Combination Therapy Market Sales by Geography (USD MN)
- Analysis Market by Drug Type (USD MN)
- Aminoglycoside Market Sales by Geography (USD MN)
- Cephalosporin Market Sales by Geography (USD MN)
- Carbapenem Market Sales by Geography (USD MN)
- Monobactam Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Analysis by Route Of Administration (USD MN)
- Nasal Market Sales by Geography (USD MN)
- Oral Market Sales by Geography (USD MN)
- Intravenous Market Sales by Geography (USD MN)
- Analysis by Distribution Channel (USD MN)
- Hospital Pharmacies Market Sales by Geography (USD MN)
- Retail Pharmacies Market Sales by Geography (USD MN)
- Online Pharmacies Market Sales by Geography (USD MN)
- Global Pseudomonas Aeruginosa Infection Treatment Market Sales by Geography (USD MN)
- North America Market Analysis (USD MN)
- United State Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate by Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisition
LIST OF FIGURES
- Research Scope of Pseudomonas Aeruginosa Infection Treatment Report
- Market Research Process
- Market Research Methodology
- Global Pseudomonas Aeruginosa Infection Treatment Market Size, by Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis by Medication Type
- Market Attractiveness Analysis by Drug Type
- Market Attractiveness Analysis by Route Of Administration
- Market Attractiveness Analysis by Distribution Channel
- Market Attractiveness Analysis by Region
- Value Chain Analysis
- Global Market Analysis by Medication Type (USD MN)
- Monotherapy Market Sales by Geography (USD MN)
- Combination Therapy Market Sales by Geography (USD MN)
- Global Market Analysis by Drug Type (USD MN)
- Aminoglycoside Market Sales by Geography (USD MN)
- Cephalosporin Market Sales by Geography (USD MN)
- Carbapenem Market Sales by Geography (USD MN)
- Monobactam Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Global Market Analysis by Route Of Administration (USD MN)
- Nasal Market Sales by Geography (USD MN)
- Oral Market Sales by Geography (USD MN)
- Intravenous Market Sales by Geography (USD MN)
- Global Market Analysis by Distribution Channel (USD MN)
- Hospital Pharmacies Market Sales by Geography (USD MN)
- Retail Pharmacies Market Sales by Geography (USD MN)
- Online Pharmacies Market Sales by Geography (USD MN)
- Global Market by Revenue
- North America Market by Revenue
- Europe Market by Revenue
- Asia Pacific Market by Revenue
- Latin America Market by Revenue
- Middle East & Africa Market by Revenue
- Recent Development in Industry
- Top Company Share Analysis
